The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Share News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.675
Bid: 0.65
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.05 (7.692%)
Open: 0.675
High: 0.675
Low: 0.675
Prev. Close: 0.675
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: N4's Nuvec success; Watkin Jones tumbles

Tue, 04th Oct 2022 11:19

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

N4 Pharma PLC, up 10% at 2.20 pence, 12-month range 1.50p-8.69p. The company announces two successful in vitro tests of Nuvec when loaded with two small interfering siRNA probes. siRNA can prevent cells from communicating, and could potentially prevent cancer cells from replicating. After announcing in September that it would focus on developing multiple loaded siRNA on Nuvec, N4 says it has now completed in vitro testing, which shows both probes were able to "significantly silence" their respective targets.

----------

AIM - LOSERS

----------

Watkin Jones PLC, down 33% at 101.69p, 12-month range 97.30p-282.08p. It expects to miss full-year profit expectations. The London-based student accommodation developer and manager says that in the first half to September 30, cost inflation was mitigated by increasing asset values, however in the second half it sees some pricing and margin "softness" on sales. It adds that two forward sales which were expected to close in September have been impacted by recent market volatility, and are now expected to go through in financial year 2023.

----------

Allergy Therapeutics PLC, down 11% at 17.00p, 12-month range 15.25p-40.50p. It pauses production at the Freeman facility, part of its Worthing, UK manufacturing site. Allergy Therapeutics says that the facility has been closed to accelerate ongoing site improvements.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
18 Dec 2023 11:17

N4 Pharma upbeat on recent Nuvec developments

(Sharecast News) - N4 Pharma updated the market on Monday on its ongoing research efforts related to Nuvec, its delivery system designed for cancer treatments and vaccines.

Read more
7 Dec 2023 18:28

TRADING UPDATES: N4 Pharma hails "encouraging" siRNA research

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
7 Dec 2023 13:20

N4 Pharma posts optimistic Nuvec research update

(Sharecast News) - N4 Pharma, a specialist pharmaceutical company focused on developing the Nuvec delivery system for cancer treatments and vaccines, issued an optimistic update on its ongoing in-vitro siRNA research efforts on Thursday.

Read more
1 Dec 2023 14:29

TRADING UPDATES: N4 launches investor hub; Capricorn production falls

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday, Thursday and Friday and not separately reported by Alliance News:

Read more
28 Sep 2023 13:28

N4 Pharma picks up controlling interest in Nanogenics

(Sharecast News) - Pharmaceutical firm N4 Pharma announced the acquisition of a controlling interest in Nanogenics on Thursday.

Read more
28 Sep 2023 10:20

N4 Pharma shares fall as places shares to fund Nanogenics stake buy

(Alliance News) - N4 Pharma PLC on Thursday said it bought a controlling interest in Nanogenics Ltd, a company with a lipid and peptide-based delivery system called Liptide.

Read more
12 Sep 2023 13:43

N4 Pharma interim loss narrows slightly as business outreach ongoing

(Alliance News) - N4 Pharma PLC on Tuesday said its business outreach is ongoing as it continued to work on getting Nuvec, its delivery system for vaccines and cancer treatment, into clinic.

Read more
25 Jul 2023 12:08

LONDON MARKET MIDDAY: Miners lift FTSE 100 as Fed meeting kicks off

(Alliance News) - Stock prices in London were largely higher at midday on Tuesday, with stimulus talks in China helping lift the mood, as attention turns to the US Federal Reserve which begins its two-day monetary policy meeting later.

Read more
25 Jul 2023 10:12

N4 Pharma shares soar on further patent grant for Nuvec in US

(Alliance News) - N4 Pharma PLC on Tuesday saw its shares rise, as it celebrated a patent grant for Nuvec in the US.

Read more
25 Jul 2023 10:04

AIM WINNERS & LOSERS: N4 Pharma shares jump on grant of US patent

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
27 Jun 2023 12:13

IN BRIEF: N4 Pharma expands Professor Yu partnership on grant award

N4 Pharma PLC - Derby, England-based pharmaceutical company focused on developing Nuvec, a delivery system for vaccines and cancer treatments - Says it will be supporting the University of Queensland as part of a recent grant award by the Australian Research Council. Professor Chengzhong Yu, senior group leader at the Australian Institute for Bioengineering & Nanotechnology, has been awarded an AUD402,115 grant - around GBP211,366 - to develop an improved nanoparticle delivery system that enhances the performance of messenger ribonucleic acid therapies.

Read more
25 Apr 2023 16:19

TRADING UPDATES: Eckoh expects profit up; LXi REIT refinances facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
25 Apr 2023 10:30

AIM WINNERS & LOSERS: FireAngel 2023 earnings below expectations

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
18 Apr 2023 14:20

TRADING UPDATES: Journeo extends contract; Biome completes fundraise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
18 Apr 2023 13:13

N4 Pharma reports progress with siRNA work

(Sharecast News) - N4 Pharma updated the market on its ongoing research work on gene-silencing technology siRNA on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.